ClinicalTrials.Veeva

Menu

A Study on Cardiopulmonary Exercise Tolerance Standards for Healthy Chinese Population (MCCS-CCPETS)

A

Affiliated Hospital of Changchun University of Chinese Medicine

Status

Not yet enrolling

Conditions

Cardiorespiratory Fitness
Oxygen Consumption

Treatments

Other: cardiopulmonary exercise testing (CPET)

Study type

Observational

Funder types

Other

Identifiers

NCT07108296
KFKT-2025-KY-010 (Other Grant/Funding Number)

Details and patient eligibility

About

This project intends to conduct a large-sample, prospective, multicenter clinical cohort study in healthy populations. By utilizing a digital cardiopulmonary rehabilitation clinical data research platform, The investigators aim to achieve automated, standardized, and uniform collection, analysis, and AI modeling of large-scale cardiopulmonary exercise testing (CPET) data. The ultimate goals are:

To establish reference standards for cardiopulmonary exercise capacity in the Chinese healthy population.

To develop machine learning-based predictive models for key CPET variables (e.g., peak VO₂) tailored to Chinese demographics.

To compare performance differences between domestically produced and imported CPET devices.

Enrollment

4,620 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Detailed medical history taken, with no symptoms of discomfort reported
  • Good physical condition, with no history of severe chronic diseases
  • No history of long - term medication use
  • Willing to undergo cardiopulmonary exercise testing, with no ST - T segment changes observed during the test
  • Age: 18 - 65 years old
  • BMI: 18.5 - 28kg/m²
  • No smoking history or quit smoking for ≥5 years
  • Physical examination reports within 2 years show no significant abnormalities.

Exclusion criteria

  • Pre - test resting blood pressure ≥160/100 mmHg (1 mmHg=0.133 kPa)
  • Chronic cardiovascular diseases, such as heart failure, coronary atherosclerotic heart disease, hypertension, congenital heart disease, cardiomyopathy, and severe arrhythmias
  • Respiratory diseases, such as chronic obstructive pulmonary disease, asthma, pulmonary artery hypertension, bronchiectasis, and respiratory failure
  • Digestive system diseases, such as peptic ulcer, gastrointestinal bleeding, hepatitis, liver cirrhosis, ulcerative colitis, Crohn's disease, chronic pancreatitis, and chronic cholecystitis
  • Endocrine system diseases, such as hyperthyroidism, hypothyroidism, diabetes, and other diseases with clear hormone abnormalities
  • Acute or chronic kidney diseases, blood system diseases, malignant tumors, and bone and joint diseases that affect activity
  • No history of acute infection within 2 weeks
  • Unable to cooperate with the examination
  • Contraindications to cardiopulmonary exercise testing: acute myocardial infarction

Trial design

4,620 participants in 1 patient group

Chinese Age-Sex-Stratified Cardiopulmonary Function Cohort (CACSF Cohort)
Treatment:
Other: cardiopulmonary exercise testing (CPET)

Trial contacts and locations

15

Loading...

Central trial contact

Head of Cardiac Rehabilitation Department

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems